After hours: March 13 at 6:55:15 PM EDT Loading Chart for ADC ...

After hours: March 13 at 6:00:06 PM EDT Loading Chart for ADCT ...

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...

Stock doesn't have any Buy/Sell Signals. Price Analysis Data details are not available.

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...